Press
Immunome Research – An Emerging Source for Great Ideas
Posted on December 6, 2011 by Annie De GrootCheck out the new publications from the EpiVax team in Volume 7, No. 2 of Immunome Research ! https://immunome-research.net/journal/index.php/immunome/issue/view/4 Research Article A comparison of two methods for T cell epitope mapping: “cell free” in vitro versus Immunoinformatics PDF Timothy James Messitt, Francis Terry, Leonard Moise, William Martin, Anne Searls De Groot Immunogenic Consensus Sequence T helper Epitopes for a Pan-Burkholderia Biodefense ...Read moreEpiVax is proud to support "Hope is a Vaccine" awards
Posted on November 27, 2011 by Annie De GrootAccess to treatment is the main reason that AIDS-related deaths have tumbled in recent years. That’s something 2011 Hope Is a Vaccine Award winners (International Category), Julio Montaner and Myron Cohen, would have predicted . . .according to UNAIDS, “An estimated 700,000 AIDS-related deaths were estimated to have been averted in 2010 alone . . ...Read moreWestin Immunogenicity Seminar September 27 2011, Tokyo, Japan
Posted on September 5, 2011 by Annie De GrootWestin Immunogenicity Seminar 2011 Tuesday, September 27, 2011 9:45 am – 6:10 pm Kiri Room The Westin Tokyo 1-4-1 Mita Meguro-ku, Tokyo 153-8580 Japan Speakers: Annie De Groot M.D. Director and Professor, Institute of Immunology and Informatics,University of Rhode Island and CEO/CSO EpiVax; Frances Terry, Immunoinformatics / Bioinformatics Specialist, EpiVax, Inc. Keizo Yoshida Ph.D., EpiVax Asia 9: 00 – 9 :45 AM Registration / Breakfast 9: ...Read moreAny Prime-Boost Mix of Injected or Spray Flu Vaccine Shields Toddlers
Posted on August 19, 2011 by Annie De GrootBroadest Immune Response from Nasal Spray Vaccine, NIH-Funded Study Finds (The following is an excerpt from an article published by the National Institute of Allergy and Infectious Diseases on August 16, 2011. Featured in the article is Dr. Daniel Hoft, who collaborates with EpiVax on vaccine research. In addition, Dr. Hoft gave a lecture titled “Romana’s Sign ...Read moreClinica Esperanza/Hope Clinic celebrates 1st Anniversary
Posted on May 30, 2011 by Annie De GrootAccording to EpiVax CEO De Groot, who is the volunteer Medical Director at Clinica Esperanza, improving access to care for uninsured patients will reduce the morbidity and mortality among the uninsured from preventable and treatable health problems. Dr. Peter Simon, medical director at the R.I. Department of Health, described the wide range of languages and ...Read moreBringing hope and healthcare to the uninsured
Posted on May 15, 2011 by Annie De Groot“We were interested in providing culturally sensitive care to ununinsured patients in the patient’s own language,” says Dr. Annie De Groot, EpiVax CEO, who is also cofounder and volunteer Medical Director of the new clinic. Last year, the clinic’s first permanent location opened.Read moreImmunogenicity and Vaccine Talks 2011
Posted on March 26, 2011 by Annie De GrootCome hear the latest updates on better proteins and vaccines by design – See our list of speaking engagements and appearances here:Read moreExpression of concern to our Japanese colleagues and friends
Posted on March 16, 2011 by Annie De GrootTo our dear friends and colleagues in Japan We have been following the events that are unfolding in Japan with great concern. Our hearts go out to the victims of the great earthquake and tsunami of March 11, 2011. Please accept our sincere condolences for any loss that you and your companies may have experienced. We apologize ...Read moreAgenda for Immunogenicity Determinants and Correlates Conference
Posted on March 5, 2011 by Annie De GrootAgenda for Immunogenicity Determinants and Correlates Conference – Valid as of March 05, 2011Read more4th Tregitope Update – Open Meeting May 11 2011
Posted on February 13, 2011 by Annie De GrootTregitopes are small peptidic regulatory T-cell epitopes derived from human immunoglobulins that activate regulatory T cells (Tregs). Tregitope therapy has broad-reaching implications, offering new treatments for autoimmune diseases (e.g. type 1 juvenile diabetes, multiple sclerosis, rheumatoid arthritis, and lupus), allergies, and transplantation rejection. In previous meetings, the members of the Tregitope Collaborators team have demonstrated ...Read moreImmunogenicity Determinants and Correlates: Registration Now Open
Posted on February 13, 2011 by Annie De GrootImmunogenicity: Determinants and Correlates is a non-commercial meeting, sponsored by the Institute for Immunology and Informatics and organized by individuals from a wide range of backgrounds including industry and academic settings. The current agenda, confirmed speakers, and the registration website are now posted for your review.Read moreAnti-Cancer Vaccine Progress at EpiVax
Posted on February 2, 2011 by Annie De GrootNew study from Rhode Island Hospital identifies a potential vaccine to prevent gastritis, ulcer disease, gastric cancer HelicoVax vaccine targets H. pylori PROVIDENCE, R.I. – A new study led by researchers at Rhode Island Hospital in collaboration with the University of Rhode Island (URI) and EpiVax. Inc, a privately owned vaccine development company in Providence, RI, has ...Read moreImmunogenicity: Determinants and Correlates
Posted on January 25, 2011 by Annie De GrootSAVE THE DATE May 9, 10 and 11 1st Immunogenicity – Determinates and Correlates Providence, RIRead moreImmunogenicity, Tregitopes and Tolerance 2011
Posted on December 21, 2010 by Annie De GrootAnnie De Groot, EpiVax CEO will be speaking at the following conferences. Please click on the links for more information. We look forward to meeting you there! Invited Speaker. Regulating Immune Response in Biologics – A Paradigm- Shifting Solution. Session: Immunogenicity Issues. 2nd Annual Advancing Biologics from the Lab to the Clinic, Amsterdam, Netherlands. January 25-26, ...Read moreEpiVax CEO Named Local Hero by Bank of America
Posted on November 21, 2010 by Annie De GrootEpiVax CEO Annie De Groot was one of 10 individuals honored by the Bank of America Neighborhood Excellence Initiative’s Local Heroes program for her volunteerism and civic engagement on November 2, 2010.Read more
Join our newsletter
We strive to provide our clients, collaborators and everyday immunology enthusiasts with valuable content. Written by our CEO/CSO Dr. Anne Dr Groot, you can expect up to date vaccine development efforts, upcoming events and so much more from our offices here in Providence, RI.